Company Data
ImmunityBio Inc.
Ticker
IBRX
Current Price
$8.535 41.78%
Market Cap
$8.4B
Price Target
Refer to Report
Volume
78.9M
52wk Range
$1.83 - $8.28
Overview
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company’s immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.